Showing results (201-210 of 406) with videos related to

Sort By:
Pageof 41
The Lancet. Neurology|November 18, 2006
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trialC Warren Olanow, Anthony H V Schapira, Peter A LeWitt, et al.
ESC Heart Failure|July 21, 2025
Rationale and design of the randomized 'early ventricular assist device'-Trial (VAD-DZHK3)Christoph Knosalla, Gloria Färber, Andreas J Rieth, et al.
Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Fasudil attenuates disease spreading in ALS - a post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Blood Purification|September 12, 2013
Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating diseaseMichael Koziolek, Johannes Mühlhausen, Tim Friede, et al.
BMC Family Practice|June 3, 2014
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary careJean-François Chenot, Thanh Duc Hua, Manar Abu Abed, et al.
European Journal of Clinical Investigation|April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational studyPaulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 3, 2026
Effects of fasudil on disease spreading in ALS - A MUNIX-based post-hoc analysis of the ROCK-ALS trialAndreas W Wolff, Andreas Leha, Jan C Koch, et al.
Pageof 41